Un panel de la FDA vota a favor de sacar del mercado un medicamento para prevenir los nacimientos prematuros
MIÉRCOLES, 19 de octubre de 2022 (HealthDay News) — Un comité asesor de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. votó el miércoles para recomendar que un controversial medicamento que tiene el objetivo de prevenir los nacimiento…
Learn MoreUn tratamiento común para la fibrilación auricular podría ser más riesgoso para las mujeres
MIÉRCOLES, 19 de octubre de 2022 (HealthDay News) — Aunque existe un tratamiento no farmacológico y común para la fibrilación auricular (FA), un trastorno del ritmo cardiaco, el procedimiento puede ser más problemático para las mujeres que para los h…
Learn MoreFDA OKs Novavax COVID Vaccine as First Booster Shot
THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, …
Learn MoreFDA OKs Novavax COVID Vaccine as First Booster Shot
THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot. On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, …
Learn MoreWeight Changes After Parkinson’s Diagnosis May Signal Thinking Declines
THURSDAY, Oct. 20, 2022 (HealthDay News) – Weight loss soon after a person is diagnosed with Parkinson’s disease may be a sign that mental declines are likely to follow, new research suggests.”Early weight loss is a common symptom in people with Parki…
Learn MoreWeight Changes After Parkinson’s Diagnosis May Signal Thinking Declines
THURSDAY, Oct. 20, 2022 (HealthDay News) – Weight loss soon after a person is diagnosed with Parkinson’s disease may be a sign that mental declines are likely to follow, new research suggests.”Early weight loss is a common symptom in people with Parki…
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn MoreStudy Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) — A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial s…
Learn More‘Friends’ Star Matthew Perry Reveals Harrowing Addiction Journey
THURSDAY, Oct. 20, 2022 (HealthDay News) – Just a few years ago, “Friends” actor Matthew Perry almost died from opioid overuse that nearly destroyed his colon and almost killed him.Now, he’s sober and wants to tell his story.Perry has written a memoir…
Learn More‘Friends’ Star Matthew Perry Reveals Harrowing Addiction Journey
THURSDAY, Oct. 20, 2022 (HealthDay News) – Just a few years ago, “Friends” actor Matthew Perry almost died from opioid overuse that nearly destroyed his colon and almost killed him.Now, he’s sober and wants to tell his story.Perry has written a memoir…
Learn More